About this Organization
Nuvilex is a biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live-cell encapsulation technology, called Cell-in-a-Box(TM).
This unique technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. The Company’s treatment for pancreatic cancer involves the use of the widely used anticancer prodrug, ifosfamide, together with encapsulated live cells that convert ifosfamide into its active or “cancer-killing” form.
Nuvilex’s subsidiary, Medical Marijuana Sciences, Inc., is dedicated to the development of cancer treatments based upon chemical constituents of marijuana known as cannabinoids.
To do so, it will examine ways to exploit the benefits of Cell-in-a-Box(TM) technology in optimizing the anticancer effectiveness of cannabinoids against cancers while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides Medical Marijuana Sciences a unique opportunity to develop “green” approaches to fighting deadly cancers, such as those of the pancreas, brain, breast and prostate, that affect hundreds of thousands of individuals worldwide every year.
In The News
June 10, 2014
Nuvilex And Medical Marijuana Sciences: Furthering Cancer Research
Cancer is a disease that affects nearly everyone in the developed world in some way or another. 1 in 2 men in the United States are predicted to develop cancer in their lifetimes. Some forms of cancer, such as pancreatic and brain cancers, are especially hard to treat with conventional technologies. Nuvilex, a biotechnology corporation based in Maryland, is looking to change that. The Story Of Nuvilex’s Cell-In-A-Box® Technology Nuvilex was …
Similar Companies
GW Pharmaceuticals (GWPH)
Porton Down, United Kingdom
GW Pharmaceuticals was founded in 1998 and is listed on both the NASDAQ Global Market (GWPH) and AIM, a market of the London Stock Exchange. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group’s lead programme is the development of a product portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic indications, including Sativex® Oromucosal Spray and Epidiolex® for childhood epilepsy.
GrowLife, Inc.
Gardena, California
GrowLife, Inc. is a publicly traded holdings company that makes and markets high end, progressive horticulture and lifestyle products right here in the USA. GrowLife Inc. is publicly traded on the OTC market under the symbol PHOT. The GrowLife portfolio includes a variety of companies that specialize in cultivation equipment, soil, and more. Their subsidiaries include GrowLife Hydroponics, Rocky Mountain Hydroponics & Organics, Evergreen Garden Center, Urban Garden, Greeners.com, Phototron, Cannabis.org, Stealth Grow, SGsensors.com, and GrowLife Productions.
Cannabis Biotech
Fort Lauderdale, Florida
Based in Fort Lauderdale, Florida, Cannabis Biotech is a subsidiary of Puget Technologies (OTC: PUGE). The publicly held company is led by President and CEO Ron Leyland. Cannabis Biotech conducts research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms. Ailments that the company has studied include HIV, cancer, glaucoma and neurological disorders. Thus far, Cannabis Biotech has developed a number of products that utilize alternative delivery methods. For instance, they have developed nasal spray and trans-dermal skin patches geared towards treatment via cannabinoids. Further, they are developing cannabis infused beverages that utilize natural …
DISCLAIMER: The professionals and companies described are not associated or affiliated with Medical Jane, and they
may not endorse Medical Jane or the information provided. The names of other companies, products and services are
the property of their respective owners.
